Oragenics, Inc. to Present Data on Its Peptide Synthesis Platform at the American Peptide Symposium
Retrieved on:
Tuesday, June 25, 2019
The presentation is scheduled on Wednesday, June 26, 2019, at the American Peptide Symposium in the Sierra Ballroom of the Monterey Conference Center in Monterey, Calif.
Key Points:
- The presentation is scheduled on Wednesday, June 26, 2019, at the American Peptide Symposium in the Sierra Ballroom of the Monterey Conference Center in Monterey, Calif.
- Presented by Dr. Jae H. Park, this work demonstrates the peptide synthesis platform developed using orthogonally-protected lanthionine building blocks.
- Following a description of the peptide synthesis, this work confirms the compounds anti-microbial activity against Staphylococcus aureus.
- This novel synthetic approach will allow the synthesis of a wide array of novel Mutacin 1140 analogs, creating multiple new therapeutic opportunities for both Gram-positive and Gram-negative indications.